| Walmart Pharmacy 10-2804 | |
| 1801 Belle Isle Blvd, Oklahoma City, Oklahoma 73118 | |
| (405) 841-6516 |
| Name | Walmart Pharmacy 10-2804 |
|---|---|
| Organization Name | Wal-mart Stores East Lp |
| Location | 1801 Belle Isle Blvd, Oklahoma City, Oklahoma 73118 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (405) 841-6516 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
OraSure Technologies, Inc. and Roche announced today that the U.S. Food and Drug Administration has granted the Companies 510(k) clearance on four homogeneous fully automated oral fluid drugs of abuse assays developed to be used exclusively as part of OraSure's Intercept Oral Fluid Drug Testing System.
On Wednesday, USAID, "along with representatives from seven government agencies and departments, launched the first-ever, whole-of-government strategic guidance on international assistance for children in adversity," a USAID press release reports.
Wound Management Technologies, Inc. is pleased to announce the sales expansion of its advanced wound care collagen product, CellerateRX, into South Africa. With EWA Government Systems and Spiramed (Pty) Ltd., the Company has obtained the registration of the product in the region and has also obtained the necessary NAPPI codes, which are a pre-requisite for any billable health product in South Africa. In addition, CellerateRX® is registered with various South African insurance companies and is an authorized product for reimbursement.
Scientists at the Institute of Molecular Biology in Mainz have identified a missing piece of the puzzle in understanding how epigenetic marks are removed from DNA. The research on DNA demethylation sheds new light on a fundamental process that is important in development and diseases such as cancer.
Asuragen, Inc. and Life Technologies Corporation announced today that they have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant™ Test, Asuragen's clinically validated and cGMP manufactured test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML). Asuragen manufacturers the monitoring test, which is exclusively distributed by Life Technologies and runs on the company's Applied Biosystems CE-marked 7500 Fast Dx Real-Time PCR Instrument™.
› Verified 8 days ago
| NPI Number | 1154348290 |
| Organization Name | WAL-MART STORES EAST LP |
| Doing Business As | WAL-MART PHARMACY 10-2804 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1801 Belle Isle Blvd, Oklahoma City, OK 73118 |
| Phone Number | 405-841-6516 |
News Archive
OraSure Technologies, Inc. and Roche announced today that the U.S. Food and Drug Administration has granted the Companies 510(k) clearance on four homogeneous fully automated oral fluid drugs of abuse assays developed to be used exclusively as part of OraSure's Intercept Oral Fluid Drug Testing System.
On Wednesday, USAID, "along with representatives from seven government agencies and departments, launched the first-ever, whole-of-government strategic guidance on international assistance for children in adversity," a USAID press release reports.
Wound Management Technologies, Inc. is pleased to announce the sales expansion of its advanced wound care collagen product, CellerateRX, into South Africa. With EWA Government Systems and Spiramed (Pty) Ltd., the Company has obtained the registration of the product in the region and has also obtained the necessary NAPPI codes, which are a pre-requisite for any billable health product in South Africa. In addition, CellerateRX® is registered with various South African insurance companies and is an authorized product for reimbursement.
Scientists at the Institute of Molecular Biology in Mainz have identified a missing piece of the puzzle in understanding how epigenetic marks are removed from DNA. The research on DNA demethylation sheds new light on a fundamental process that is important in development and diseases such as cancer.
Asuragen, Inc. and Life Technologies Corporation announced today that they have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant™ Test, Asuragen's clinically validated and cGMP manufactured test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML). Asuragen manufacturers the monitoring test, which is exclusively distributed by Life Technologies and runs on the company's Applied Biosystems CE-marked 7500 Fast Dx Real-Time PCR Instrument™.
› Verified 8 days ago
News Archive
OraSure Technologies, Inc. and Roche announced today that the U.S. Food and Drug Administration has granted the Companies 510(k) clearance on four homogeneous fully automated oral fluid drugs of abuse assays developed to be used exclusively as part of OraSure's Intercept Oral Fluid Drug Testing System.
On Wednesday, USAID, "along with representatives from seven government agencies and departments, launched the first-ever, whole-of-government strategic guidance on international assistance for children in adversity," a USAID press release reports.
Wound Management Technologies, Inc. is pleased to announce the sales expansion of its advanced wound care collagen product, CellerateRX, into South Africa. With EWA Government Systems and Spiramed (Pty) Ltd., the Company has obtained the registration of the product in the region and has also obtained the necessary NAPPI codes, which are a pre-requisite for any billable health product in South Africa. In addition, CellerateRX® is registered with various South African insurance companies and is an authorized product for reimbursement.
Scientists at the Institute of Molecular Biology in Mainz have identified a missing piece of the puzzle in understanding how epigenetic marks are removed from DNA. The research on DNA demethylation sheds new light on a fundamental process that is important in development and diseases such as cancer.
Asuragen, Inc. and Life Technologies Corporation announced today that they have achieved CE-marking and commercial launch in Europe of the BCR/ABL1 Quant™ Test, Asuragen's clinically validated and cGMP manufactured test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML). Asuragen manufacturers the monitoring test, which is exclusively distributed by Life Technologies and runs on the company's Applied Biosystems CE-marked 7500 Fast Dx Real-Time PCR Instrument™.
› Verified 8 days ago
180 Medical Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 8516 Nw Expressway, Oklahoma City, Oklahoma 73162 Phone: (877) 688-2729 | |
Rehab Medical Supply Type: Medicare Supplier Location: 4601 N May Ave, Oklahoma City, Oklahoma 73112 Phone: (405) 947-6162 | |
Accente, Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11629 S Western Ave, Oklahoma City, Oklahoma 73170 Phone: (405) 703-3143 | |
Accredo Health Group, Inc. Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4901 W Reno Ave, Oklahoma City, Oklahoma 73127 Phone: (405) 942-3961 | |
Aerocare Home Medical Equipment Inc Type: DME Supplier - Oxygen Equipment & Supplies Location: 6125 W Reno Ave, Ste 100, Oklahoma City, Oklahoma 73127 Phone: (405) 943-2200 |